Carlos Martínez‐Rivera

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

Tim Harrison, Pascal Chanez, Francesco Menzella et al. · The Lancet Respiratory Medicine · 2020 · 175 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +15

Clinical Audit of COPD Patients Requiring Hospital Admissions in Spain: AUDIPOC Study

Francisco Pozo-Rodrı́guez, José Luís López-Campos, Carlos Martínez‐Rivera et al. · PLoS ONE · 2012 · 112 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Usefulness of Truncal Obesity Indices as Predictive Factors for Obstructive Sleep Apnea Syndrome

Carlos Martínez‐Rivera, Jorge Abad, J.A. Fiz et al. · Obesity · 2008 · 105 citations · Full text

Medicine, Otolaryngology, Obesity Prevention +15

Anemia is a Mortality Predictor in Hospitalized Patients for COPD Exacerbation

Carlos Martínez‐Rivera, Karina Portillo, Aída Selfa Muñoz et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2012 · 77 citations

Medicine, Hematology, Internal Medicine +8

Treatment of Chronic Diabetic Foot Ulcers with Adipose-Derived Stromal Vascular Fraction Cell Injections: Safety and Evidence of Efficacy at 1 Year

Michael H. Carstens, Francisco J. Quintana, Santos T. Calderwood et al. · Stem Cells Translational Medicine · 2021 · 76 citations · Full text

Medicine, Orthopaedic Surgery, Surgery +17